BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 34722778)

  • 1. circ_0001588 Induces the Malignant Progression of Hepatocellular Carcinoma by Modulating miR-874/CDK4 Signaling.
    Bin X; Chen Y; Ma J; Tang R; Zhao Z; Wang K; Wang J
    J Immunol Res; 2021; 2021():3759879. PubMed ID: 34722778
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Circ_0001178 regulates miR-382/VEGFA axis to facilitate hepatocellular carcinoma progression.
    Gao S; Hu W; Huang X; Huang X; Chen W; Hao L; Chen Z; Wang J; Wei H
    Cell Signal; 2020 Aug; 72():109621. PubMed ID: 32240747
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Circ_0015756 promotes proliferation, invasion and migration by microRNA-7-dependent inhibition of FAK in hepatocellular carcinoma.
    Liu L; Yang X; Li NF; Lin L; Luo H
    Cell Cycle; 2019 Nov; 18(21):2939-2953. PubMed ID: 31522588
    [No Abstract]   [Full Text] [Related]  

  • 4. Circular RNA circ-102,166 acts as a sponge of miR-182 and miR-184 to suppress hepatocellular carcinoma proliferation and invasion.
    Li R; Deng Y; Liang J; Hu Z; Li X; Liu H; Wang G; Fu B; Zhang T; Zhang Q; Yang Y; Chen G; Liu W
    Cell Oncol (Dordr); 2021 Apr; 44(2):279-295. PubMed ID: 33034848
    [TBL] [Abstract][Full Text] [Related]  

  • 5. circRNA hsa_circ_104566 Sponged miR-338-3p to Promote Hepatocellular Carcinoma Progression.
    Liu G; Guo W; Rao M; Qin J; Hu F; Li K
    Cell Transplant; 2020; 29():963689720963948. PubMed ID: 33028110
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Silencing of hsa_circ_0101145 reverses the epithelial-mesenchymal transition in hepatocellular carcinoma via regulation of the miR-548c-3p/LAMC2 axis.
    Jin J; Liu H; Jin M; Li W; Xu H; Wei F
    Aging (Albany NY); 2020 Jun; 12(12):11623-11635. PubMed ID: 32554866
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Circular RNA hsa_circ_0016788 regulates hepatocellular carcinoma tumorigenesis through miR-486/CDK4 pathway.
    Guan Z; Tan J; Gao W; Li X; Yang Y; Li X; Li Y; Wang Q
    J Cell Physiol; 2018 Jan; 234(1):500-508. PubMed ID: 29923236
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Exosomal hsa_circ_0004658 derived from RBPJ overexpressed-macrophages inhibits hepatocellular carcinoma progression via miR-499b-5p/JAM3.
    Zhang L; Zhang J; Li P; Li T; Zhou Z; Wu H
    Cell Death Dis; 2022 Jan; 13(1):32. PubMed ID: 35013102
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hsa_circ_0026134 expression promoted TRIM25- and IGF2BP3-mediated hepatocellular carcinoma cell proliferation and invasion via sponging miR-127-5p.
    Zhang W; Zhu L; Yang G; Zhou B; Wang J; Qu X; Yan Z; Qian S; Liu R
    Biosci Rep; 2020 Jul; 40(7):. PubMed ID: 32648571
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Circ-EIF3I Promotes Hepatocellular Carcinoma Progression Through Modulating miR-361-3p/DUSP2 Axis.
    Ni L; Gao Q; Zhao Q; Dai K; Jin M; Fu C; Xiao M; Zhu W; Bi Y
    DNA Cell Biol; 2024 May; 43(5):258-266. PubMed ID: 38513057
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Circ_0091579 Serves as a Tumor-Promoting Factor in Hepatocellular Carcinoma Through miR-1225-5p/PLCB1 Axis.
    Zhang D; Zhang Y; Zhang X; Zhai H; Sun X; Li Y
    Dig Dis Sci; 2022 Feb; 67(2):585-597. PubMed ID: 33559088
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CircRNA hsa_circ_0110102 inhibited macrophage activation and hepatocellular carcinoma progression via miR-580-5p/PPARα/CCL2 pathway.
    Wang X; Sheng W; Xu T; Xu J; Gao R; Zhang Z
    Aging (Albany NY); 2021 Apr; 13(8):11969-11987. PubMed ID: 33891564
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Circ-TCF4.85 silencing inhibits cancer progression through microRNA-486-5p-targeted inhibition of ABCF2 in hepatocellular carcinoma.
    Gao J; Dai C; Yu X; Yin XB; Zhou F
    Mol Oncol; 2020 Feb; 14(2):447-461. PubMed ID: 31758671
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Elevated expression of circular RNA circ_0008450 predicts dismal prognosis in hepatocellular carcinoma and regulates cell proliferation, apoptosis, and invasion via sponging miR-548p.
    Zhang J; Chang Y; Xu L; Qin L
    J Cell Biochem; 2019 Jun; 120(6):9487-9494. PubMed ID: 30556306
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hsa_circ_0079875 functions as a competitive endogenous RNA to promote hepatocellular carcinoma progression.
    Liu Y; Luo X; Chen W; Dong Z; Cheng T; Chen L; Ju L; Cai W; Bian Z
    Cell Cycle; 2024 Mar; 23(5):519-536. PubMed ID: 38684479
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Circular RNA hsa_circ_0005239 contributes to hepatocellular carcinoma cell migration, invasion, and angiogenesis by targeting the miR-34a-5p/PD-L1 axis.
    He T; Huang J; Liang H; Zhong B; Xu G; Zhu X
    Cell Biol Int; 2023 Sep; 47(9):1519-1534. PubMed ID: 37208963
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Circ_0091581 Promotes the Progression of Hepatocellular Carcinoma Through Targeting miR-591/FOSL2 Axis.
    Ji C; Hong X; Lan B; Lin Y; He Y; Chen J; Liu X; Ye W; Mo Z; She Z; Lin S
    Dig Dis Sci; 2021 Sep; 66(9):3074-3085. PubMed ID: 33040214
    [TBL] [Abstract][Full Text] [Related]  

  • 18. circ-BIRC6, a circular RNA, promotes hepatocellular carcinoma progression by targeting the miR-3918/Bcl2 axis.
    Yang G; Wang X; Liu B; Lu Z; Xu Z; Xiu P; Liu Z; Li J
    Cell Cycle; 2019 May; 18(9):976-989. PubMed ID: 30931701
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Circular RNA hsa_circ_0005397 promotes hepatocellular carcinoma progression by regulating the miR-326/PDK2 axis.
    Gong J; Du C; Sun N; Xiao X; Wu H
    J Gene Med; 2021 Jun; 23(6):e3332. PubMed ID: 33783904
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CircRNA hsa_circRNA_104348 promotes hepatocellular carcinoma progression through modulating miR-187-3p/RTKN2 axis and activating Wnt/β-catenin pathway.
    Huang G; Liang M; Liu H; Huang J; Li P; Wang C; Zhang Y; Lin Y; Jiang X
    Cell Death Dis; 2020 Dec; 11(12):1065. PubMed ID: 33311442
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.